MOGAD optic neuritis after mild head/orbital trauma in six children

Alexander J Sandweiss1, Jonathan Rosen1, Chaitanya Aduru1

  • 1Department of Pediatrics, Section of Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States of America.

PubMed

Insights

Mild head trauma may trigger myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) presenting as optic neuritis (ON) in young patients. This suggests a potential non-infectious trigger for MOGAD-ON.

Area of Science:

  • Neurology
  • Immunology
  • Ophthalmology

Background:

  • Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating condition that can cause optic neuritis (ON).
  • The precise triggers and underlying causes of MOGAD are not fully understood.
  • Head trauma is not typically recognized as a direct trigger for MOGAD.

Purpose of the Study:

  • To investigate a potential link between mild head/orbital trauma and the onset of MOGAD-ON in young patients.
  • To describe a novel clinical observation of MOGAD-ON following head trauma.

Main Methods:

  • A single-center retrospective case series comparing six young patients with MOGAD-ON following head trauma to age-matched controls with isolated MOGAD-ON.
  • Data collection included patient demographics, trauma history, clinical presentation, MOGAD diagnosis, treatment, and outcomes.

Main Results:

  • Six patients (8-18 years old) developed ON approximately 5.5 days after mild head trauma, all testing positive for anti-MOG antibodies.
  • Four patients had unilateral ON after unilateral trauma; two had bilateral ON after midline trauma.
  • All patients responded rapidly to intravenous corticosteroids, with full visual recovery within 5.5 weeks and no relapses.

Conclusions:

  • Mild head trauma may act as an inciting event for MOGAD-ON in susceptible individuals.
  • This finding suggests a potential non-infectious pathophysiologic mechanism for MOGAD-ON.
  • Further research is needed to determine if head trauma predisposes individuals to MOGAD-ON.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
482
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.5K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
402